The TGF-beta response to Leishmania chagasi in the absence of IL-12 (Q28590373)

Cyclin-dependent kinase 5, regulatory subunit 1 (p35)

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Judy A Streit

1 reference

ORCID Public Data File 2021

author name string

Mary E. Wilson

1

1 reference

31 January 2017

Thomas J. Recker

2

1 reference

31 January 2017

Nilda E. Rodriguez

3

1 reference

31 January 2017

Betty M. Young

4

1 reference

31 January 2017

Kindra K. Burnell

5

1 reference

31 January 2017

Judy A. Streit

6

1 reference

31 January 2017

Joel N. Kline

European Journal of Immunology

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

31 January 2017

1 reference

31 January 2017

32

1 reference

31 January 2017

3556–3565

1 reference

31 January 2017

12

1 reference

31 January 2017

Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

The role of IL-12 in maintaining resistance to Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

IL-12 is required to maintain a Th1 response during Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

Host susceptibility factors to cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200212%2932%3A12%3C3556%3A%3AAID-IMMU3556%3E3.0.CO%3B2-Q

10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4193991

4193991

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference